InvestorsHub Logo
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

Re: jerrydylan post# 24774

Thursday, 04/02/2009 4:24:20 PM

Thursday, April 02, 2009 4:24:20 PM

Post# of 52265
Well, Lilly's compound made it through Phase I also. Sometimes you don't catch these infrequent side effects until you are in larger-scale trials with patient populations. So we cannot totally assume CX-1739 will never encounter any problems (CX-717 is a good example of this).

NeuroInvestment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News